MIDDLEFIELD LTD HEALTHCARE DIVIDEND ETFMIDDLEFIELD LTD HEALTHCARE DIVIDEND ETFMIDDLEFIELD LTD HEALTHCARE DIVIDEND ETF

MIDDLEFIELD LTD HEALTHCARE DIVIDEND ETF

No trades
See on Supercharts

Key stats


Assets under management (AUM)
‪137.52 M‬CAD
Fund flows (1Y)
‪−7.58 M‬CAD
Dividend yield (indicated)
5.70%
Discount/Premium to NAV
−0.3%
Shares outstanding
‪13.04 M‬
Expense ratio
1.36%

About MIDDLEFIELD LTD HEALTHCARE DIVIDEND ETF


Issuer
Middlefield Group
Brand
Middlefield
Inception date
Feb 12, 2019
Index tracked
No Underlying Index
Management style
Active
Dividend treatment
Distributes
Primary advisor
Middlefield Ltd.
The fund aims for stable monthly cash distributions and long-term returns by investing in dividend-paying securities of global companies operating in, or deriving a significant portion of their revenue or earnings, from products and services related to healthcare, life sciences, and other similar industries. The fund adviser believes these industries could to potentially generate strong risk-adjusted returns and present long-term investment opportunities by benefitting from a growing population with aging demographics, longer life expectancies, rising healthcare utilization, and increased spending on the treatment and prevention of chronic illnesses.

Classification


Asset Class
Equity
Category
Sector
Focus
Health care
Niche
Pharma, biotech & life sciences
Strategy
Active
Geography
Global
Weighting scheme
Proprietary
Selection criteria
Proprietary

Returns


1 month3 monthsYear to date1 year3 years5 years
Price performance
NAV total return

What's in the fund


As of December 31, 2024
Exposure type
StocksBonds, Cash & Other
Health Technology
Health Services
Stocks98.14%
Health Technology77.46%
Health Services10.35%
Finance7.65%
Distribution Services2.67%
Bonds, Cash & Other1.86%
Cash1.86%
Stock breakdown by region
83%16%
North America83.46%
Europe16.54%
Latin America0.00%
Asia0.00%
Africa0.00%
Middle East0.00%
Oceania0.00%
Top 10 holdings

Dividends


Dividend payout history

Assets under management (AUM)



Fund Flows



Frequently Asked Questions


MHCD invests in stocks. The fund's major sectors are Health Technology, with 77.46% stocks, and Health Services, with 10.35% of the basket. The assets are mostly located in the North America region.
MHCD top holdings are Eli Lilly and Company and UnitedHealth Group Incorporated, occupying 7.08% and 6.00% of the portfolio correspondingly.
MHCD last dividends amounted to 0.05 CAD. The month before, the issuer paid 0.05 CAD in dividends,
MHCD assets under management is ‪137.52 M‬ CAD. It's fallen 1.99% over the last month.
MHCD fund flows account for ‪−7.58 M‬ CAD (1 year). Many traders use this metric to get insight into investors' sentiment and evaluate whether it's time to buy or sell the fund.
Yes, MHCD pays dividends to its holders with the dividend yield of 5.70%. The last dividend (Aug 15, 2025) amounted to 0.05 CAD. The dividends are paid monthly.
MHCD shares are issued by Middlefield Group under the brand Middlefield. The ETF was launched on Feb 12, 2019, and its management style is Active.
MHCD expense ratio is 1.36% meaning you'd have to pay 1.36% of your investment to help manage the fund.
MHCD follows the No Underlying Index. ETFs usually track some benchmark seeking to replicate its performance and guide asset selection and objectives.
MHCD invests in stocks.
MHCD price has fallen by −2.86% over the last month, and its yearly performance shows a −13.12% decrease. See more dynamics on MHCD price chart.
NAV returns, another gauge of an ETF dynamics, have fallen by −1.69% over the last month, showed a −3.74% decrease in three-month performance and has decreased by −6.97% in a year.
MHCD trades at a premium (0.30%) meaning the ETF is trading at a higher price than the calculated NAV.